Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer

While tumor genotyping is the standard treatment for patients with non-small cell lung cancer (NSCLC), spatial and temporal tumor heterogeneity and insufficient specimens can lead to limitations in the use of tissue-based sequencing. Circulating tumor DNA (ctDNA) fully encompasses tumor-specific seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hua, Zhang, Junjie, Zhang, Lemeng, Wen, Xiaoping, Luo, Yongzhong, Yao, Dingquan, Cheng, Tianli, Cheng, Huanqing, Wang, Huina, Lou, Feng, Guo, Jing, Liang, Xiayuan, Cao, Shanbo, Chen, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781496/
https://www.ncbi.nlm.nih.gov/pubmed/31611986
http://dx.doi.org/10.3892/ol.2019.10791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781496/
https://www.ncbi.nlm.nih.gov/pubmed/31611986
http://dx.doi.org/10.3892/ol.2019.10791

Ejemplares similares